Lattanzio, Frank A.

Lattanzio, Frank A.
Close

Positions

Retired, Physiological Sciences 2023 -

Contact Info

lattanfa@evms.edu

selected publications

2019

Countering the Modern Metabolic Disease Rampage With Ancestral Endocannabinoid System Alignment. FRONTIERS IN ENDOCRINOLOGY. 10.
Full Text via DOI: 10.3389/fendo.2019.00311 PMID: 31156558
2019

Peptide Inhibitor of Complement C1 (PIC1) Inhibits Growth of Pathogenic Bacteria. INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS. 25:83-92.
Full Text via DOI: 10.1007/s10989-017-9651-z
2018

Peptide inhibitor of complement C1 modulates transfusion related acute lung injury in a novel rat model. MOLECULAR IMMUNOLOGY. 177-177.
Full Text via DOI: 10.1016/j.molimm.2018.06.129
2017

Therapeutic hypothermia modulates complement factor C3a and C5a levels in a rat model of hypoxic ischemic encephalopathy. PEDIATRIC RESEARCH. 81:654-662.
Full Text via DOI: 10.1038/pr.2016.271 PMID: 28002390
2017

Learner Improvement From a Simulation-Enhanced Ultrasonography Curriculum for First-Year Medical Students. JOURNAL OF ULTRASOUND IN MEDICINE. 36:609-619.
Full Text via DOI: 10.7863/ultra.15.12025 PMID: 28127792
2017

Alterations in expression of endometrial milk fat globule-EGF factor 8 (MFG-E8) and leukemia inhibitory factor (LIF) in patients with infertility and endometriosis. JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA. 21:313-320.
Full Text via DOI: 10.5935/1518-0557.20170056 PMID: 28967712
2016

Peptide inhibitor of complement C1 modulates acute intravascular hemolysis of mismatched red blood cells in rats. TRANSFUSION. 56:2133-2145.
Full Text via DOI: 10.1111/trf.13674 PMID: 27282513
2015

Peptide Inhibitor of Complement C1 (PIC1) inhibits human red blood cell destruction in a rat model of acute intravascular hemolytic transfusion reaction (AIHTR). MOLECULAR IMMUNOLOGY. 154-154.
2015

Peptide Inhibitor of Complement significantly reduces brain injury in a rat model of neonatal hypoxic ischemic encephalopathy. MOLECULAR IMMUNOLOGY. 181-182.
2015

Therapeutic hypothermia modulates C3a and C5a levels in a rat model of neonatal hypoxic ischemic encephalopathy. MOLECULAR IMMUNOLOGY. 181-181.
2015

Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats. PLOS ONE. 10.
Full Text via DOI: 10.1371/journal.pone.0132446 PMID: 26196285
2015

Jellyfish Model for Ototoxicity. OTOLOGY & NEUROTOLOGY. 36:329-335.
Full Text via DOI: 10.1097/MAO.0000000000000402 PMID: 24786541
2014

Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis. TRANSFUSION. 54:2892-2900.
Full Text via DOI: 10.1111/trf.12695 PMID: 24806146
2014

MINIMAL SYSTEMIC ABSORPTION AND ROBUST SAFETY PROFILE OF OC-10X, A VASCULAR DISRUPTING AGENT, AFTER TOPICAL APPLICATION IN NORMAL SUBJECTS. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE.
2014

Non-invasive measurement of brain temperature using radiometric thermometry: experimental validation and clinical observations in asphyxiated newborns.. Journal of neonatal-perinatal medicine. 279-86.
Full Text via DOI: 10.3233/NPM-14814041 PMID: 25468621
2013

Expression of eNOS and VEGF in Normoxia Mediated Vasculopathy in Rat Retinopathy of Prematurity Model. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE.
2013

A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility. MOLECULAR IMMUNOLOGY. 53:132-139.
Full Text via DOI: 10.1016/j.molimm.2012.07.012 PMID: 22906481
2012

Efficacy of a Phosphorodiamidate Morpholino Oligomer Antisense Compound in the Inhibition of Corneal Transplant Rejection in a Rat Cornea Transplant Model. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS. 28:194-201.
Full Text via DOI: 10.1089/jop.2011.0135 PMID: 22149555
2012

Accelerated Atherosclerosis in Apoe(-/-) Mice Heterozygous for the Insulin Receptor and the Insulin Receptor Substrate-1. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 32:247-U172.
Full Text via DOI: 10.1161/ATVBAHA.111.240358 PMID: 22199371
2011

Lacritin, a Novel Human Tear Glycoprotein, Promotes Sustained Basal Tearing and Is Well Tolerated. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 52:6265-6270.
Full Text via DOI: 10.1167/iovs.10-6220 PMID: 21087963
2010

3,4-Methylenedioxymethamphetamine Alters Left Ventricular Function and Activates Nuclear Factor-Kappa B (NF-kappa B) in a Time and Dose Dependent Manner. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 11:4843-4863.
Full Text via DOI: 10.3390/ijms11124743 PMID: 21614177
2010

Comparison of the Pharmacokinetics of WIN 55212-2 and Latanoprost in the Human Cornea Versus the Human Sclera. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE.
2010

Lacritin, a Novel Tear Glycoprotein, is an Effective Topical Treatment in Dry Eye Animal Models. FASEB JOURNAL.
2010

The Terminal Regions of Lacritin May Contain Functional Domains That Increase Tear Flow. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE.
2008

Propylaminated Biotinylglycans: Useful Reagents for Glycobiological Investigations. GLYCOBIOLOGY. 983-983.
2008

Lacritin, a Novel Tear Glycoprotein, Stimulates Tear Production in Rabbits without Ocular Toxicity. FASEB JOURNAL.
2008

Novel free radical scavengers protect retinal cells and decrease elevated intraocular pressure in a rat ocular hypertension model. FASEB JOURNAL.
2008

Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor-mediated mechanism of action. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS. 24:104-115.
Full Text via DOI: 10.1089/jop.2007.0074 PMID: 18201139
2008

Comparison of topical and intravenous administration of WIN 55-212-2 in normotensive rabbits. CURRENT EYE RESEARCH. 33:857-863.
Full Text via DOI: 10.1080/02713680802419724 PMID: 18853319
2007

Proteomic and fractal analysis of a phenotypic transition in the growth of human breast cells in culture. JOURNAL OF STATISTICAL MECHANICS-THEORY AND EXPERIMENT.
Full Text via DOI: 10.1088/1742-5468/2007/12/P12006
2007

Analysis of protein-linked glycosylation in a sperm-somatic cell adhesion system. GLYCOBIOLOGY. 17:553-567.
Full Text via DOI: 10.1093/glycob/cwm025 PMID: 17337520
2007

Ocular pharmacokinetics and pharmacodynamics of synthetic cannabinoid, O-1812, in a perfused rat eye model. FASEB JOURNAL. A417-A417.
2006

Primate granulosa cell response via prostaglandin E2 receptors increases late in the periovulatory interval. BIOLOGY OF REPRODUCTION. 75:868-876.
Full Text via DOI: 10.1095/biolreprod.106.053769 PMID: 16943366
2006

The expression of bisecting type N-glycans and ligands for DC-SIGN on human sperm. GLYCOBIOLOGY. 1161-1161.
2006

Chronic topical administration of WIN-55-212-2 maintains a reduction in IOP in a rat glaucoma model without adverse effects. EXPERIMENTAL EYE RESEARCH. 82:753-759.
Full Text via DOI: 10.1016/j.exer.2005.09.017 PMID: 16289049
2006

Effects of novel free radical scavengers on intraocular pressure and electroretinograms in rat glaucoma models. FASEB JOURNAL. A689-A689.
2006

Novel endocannabinoids reduce intraocular pressure in a rat glaucoma model. FASEB JOURNAL. A682-A682.
2006

Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether. AMERICAN JOURNAL OF OPHTHALMOLOGY. 141:524-529.
Full Text via DOI: 10.1016/j.ajo.2005.11.003 PMID: 16490500
2006

Differential O-glycosylation of a conserved domain expressed in murine and human ZP3. BIOCHEMISTRY. 45:637-647.
Full Text via DOI: 10.1021/bi0512804 PMID: 16401092
2005

Cyclosporin as an adjunct to glaucoma filtration surgery. JOURNAL OF GLAUCOMA. 14:441-447.
2005

Do injections of 5-fluorouracil after trabeculectomy have toxic effects on the anterior segment?. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS. 21:223-235.
2005

Confocal microscopy used as the definitive, early diagnostic method in Chandler syndrome. CORNEA. 24:227-229.

full name

Frank A. Lattanzio

visualizations

Recent publications and grants in Researchers@EVMS

Co-author Network

research areas